Complete Filing Data
Cannabis Bioscience International Holdings, Inc. reported Stockholders Equity of -$591.7 thousand for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Cannabis Bioscience International Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income * | -$548.8K | -$651.3K | -$1.0M |
| Cost of Revenue * | $40.1K | $45.6K | $93.5K |
| Revenue * | $303.0K | $248.8K | $316.8K |
| Operating Income Loss | -$421.4K | -$486.1K | -$983.4K |
| Nonoperating Income Expense | -$127.5K | -$165.2K | -$49.2K |
| Gross Profit | $262.9K | $203.2K | $223.4K |
| General And Administrative Expense | $101.9K | $123.8K | $177.1K |
| Operating Expenses | $684.3K | $689.4K | $1.2M |
| Interest Expense Nonoperating | $136.3K | $154.2K | $91.0K |
| Other Nonoperating Expense | $0.00 | $11.0K | |
| Interest Expense | |||
| Other Nonoperating Income | |||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease | |||
| Net Income Loss Attributable To Noncontrolling Interest | |||
| Income Taxes Paid Net | |||
| Income Tax Expense Benefit | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | |||
| Cost Of Construction Materials Sold | |||
| Construction Materials Revenue |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2012 | Q4 2011 | Q1 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$117.0K | -$82.6K | -$79.5K | -$76.3K | -$209.2K | -$124.4K | -$181.8K | -$324.7K | -$219.9K | -$212.0K | -$1.2M | $1.8M | -$1.7M | $4.9M |
| Cost of Revenue * | $10.5K | $8.1K | $7.8K | $8.4K | $11.8K | $15.1K | $8.8K | $24.1K | $7.1K | $6.8M | $10.5M | $12.3M | $18.7M | |
| Revenue * | $53.3K | $24.2K | $74.2K | $178.9K | $36.4K | $63.7K | $72.8K | $51.3K | $82.6K | $8.6M | $15.5M | $20.8M | $25.9M | |
| Operating Income Loss | -$95.9K | -$74.8K | -$59.6K | -$97.6K | -$160.0K | -$94.5K | -$176.8K | -$284.9K | -$183.6K | -$1.0M | $2.8M | -$1.6M | $5.4M | |
| Nonoperating Income Expense | -$21.1K | -$7.9K | -$19.9K | $21.3K | -$49.2K | -$29.9K | -$5.0K | -$39.8K | -$36.3K | -$4.0K | $64.1K | $95.2K | -$51.5K | |
| Gross Profit | $42.8K | $16.1K | $66.4K | $170.5K | $24.6K | $48.7K | $64.0K | $27.1K | $75.5K | $1.8M | $5.0M | $8.5M | $7.2M | |
| General And Administrative Expense | $31.0K | $23.3K | $40.1K | $61.3K | $25.3K | $8.4K | $48.1K | $48.5K | $21.0K | $2.8M | $2.1M | $10.1M | $1.9M | |
| Operating Expenses | $138.6K | $90.8K | $126.1K | $268.1K | $184.6K | $143.2K | $240.8K | $312.0K | $259.1K | |||||
| Interest Expense Nonoperating | $17.9K | $17.4K | $8.7K | $2.3K | $5.0K | |||||||||
| Other Nonoperating Expense | $3.2K | $11.2K | $0.00 | $0.00 | $0.00 | $8.9K | ||||||||
| Interest Expense | $49.2K | $29.9K | $39.8K | $36.3K | $12.3K | $10.3K | $51.7K | $51.6K | ||||||
| Other Nonoperating Income | $8.3K | $74.4K | $137.7K | $8.5K | ||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease | -$821.1K | -$26.4K | -$887.9K | -$985.3K | ||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$54.6K | $157.7K | -$69.5K | $271.2K | ||||||||||
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | |||||||||||
| Income Tax Expense Benefit | $272.1K | $936.5K | $273.4K | $174.2K | ||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.0M | $2.9M | -$1.5M | $5.3M | ||||||||||
| Cost Of Construction Materials Sold | $6.7M | $10.4M | $11.5M | $17.7M | ||||||||||
| Construction Materials Revenue | $8.5M | $15.0M | $18.2M | $22.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity * | -$591.7K | -$361.1K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $8.9K | $32.0K | ||
| Gains Losses On Extinguishment Of Debt | $23.6K | $0.00 | $41.8K | |
| Retained Earnings Accumulated Deficit | -$5.3M | -$4.7M | ||
| Preferred Stock Value | $0.00 | $0.00 | ||
| Liabilities Noncurrent | $254.3K | $249.5K | ||
| Liabilities Current | $881.9K | $385.5K | ||
| Liabilities And Stockholders Equity | $57.2K | $43.4K | ||
| Liabilities | $1.1M | $635.0K | ||
| Common Stock Value | $0.00 | $0.00 | ||
| Assets Current | $21.5K | $19.5K | ||
| Assets | $57.2K | $43.4K | ||
| Accounts Receivable Net Current | $20.1K | $10.0K | ||
| Operating Lease Expense | $65.3K | $86.7K | $71.9K | |
| Operating Lease Right Of Use Asset | $35.7K | $23.9K | ||
| Operating Lease Liability Current | $21.9K | $4.4K | ||
| Long Term Loans Payable | $249.4K | $249.5K | ||
| Loans Payable Current | $7.1K | $14.6K | ||
| Accounts Payable And Accrued Liabilities Current | $165.9K | $111.3K | ||
| Other Assets Current | $598.00 | $598.00 | ||
| Operating Lease Liability Noncurrent | $0.00 | $4.9K | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $12.2K | -$8.2K | -$23.1K | |
| Cash And Cash Equivalents At Carrying Value | ||||
| Repayments Of Related Party Debt | $0.00 | $19.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2012 | Q4 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$1.4M | -$1.2M | -$1.2M | -$1.1M | -$1.1M | -$1.1M | -$976.1K | -$841.9K | -$717.5K | -$481.7K | -$405.3K | -$498.1K | $69.3M | $69.7M | $62.2M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $132.00 | $223.00 | $13.0K | $1.0K | $969.00 | $755.00 | $794.00 | $337.00 | $4.7K | $25.7K | $24.1K | |||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $23.6K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Retained Earnings Accumulated Deficit | -$6.1M | -$6.0M | -$5.9M | -$5.4M | -$5.2M | -$5.2M | $18.4M | $19.7M | $14.8M | |||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Liabilities Noncurrent | $249.5K | $249.5K | $249.5K | $249.5K | $269.0K | $283.4K | $153.8K | $549.2K | $515.7K | |||||||||
| Liabilities Current | $1.1M | $1.0M | $946.0K | $852.1K | $801.0K | $660.3K | $35.1M | $36.3M | $27.5M | |||||||||
| Liabilities And Stockholders Equity | $22.1K | $18.9K | $31.9K | $46.3K | $94.0K | $101.8K | $108.8M | $110.9M | $93.0M | |||||||||
| Liabilities | $1.4M | $1.3M | $1.2M | $1.1M | $1.1M | $943.7K | $35.2M | $36.9M | $28.0M | |||||||||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $44.7M | $44.6M | $43.3M | |||||||||
| Assets Current | $22.1K | $18.9K | $29.1K | $18.7K | $18.4K | $19.7K | $24.5M | $49.3M | $31.5M | |||||||||
| Assets | $22.1K | $18.9K | $31.9K | $46.3K | $94.0K | $101.8K | $108.8M | $110.9M | $93.0M | |||||||||
| Accounts Receivable Net Current | $21.8K | $9.0K | $6.4K | $17.2K | $17.0K | $19.4K | $22.8M | $47.5M | $30.1M | |||||||||
| Operating Lease Expense | $11.3K | $11.1K | $18.4K | $18.2K | $21.0K | |||||||||||||
| Operating Lease Right Of Use Asset | $0.00 | $0.00 | $2.8K | $27.5K | $75.5K | $23.9K | ||||||||||||
| Operating Lease Liability Current | $0.00 | $0.00 | $4.9K | $22.2K | $56.0K | $4.4K | ||||||||||||
| Long Term Loans Payable | $249.5K | $249.5K | $249.5K | $249.5K | $249.5K | $249.5K | ||||||||||||
| Loans Payable Current | $14.6K | $14.6K | $14.6K | $7.1K | $7.1K | $12.1K | ||||||||||||
| Accounts Payable And Accrued Liabilities Current | $159.1K | $101.3K | $100.3K | $136.3K | $257.5K | $213.5K | ||||||||||||
| Other Assets Current | $188.00 | $598.00 | $598.00 | $598.00 | $598.00 | |||||||||||||
| Operating Lease Liability Noncurrent | $0.00 | $19.5K | $0.00 | |||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$12.7K | $214.00 | -$4.2K | |||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $73.5K | $289.9K | $136.7K | $351.0K | $803.5K | $1.1M | ||||||||||||
| Repayments Of Related Party Debt | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$329.6K | -$479.4K | -$898.4K |
| Increase Decrease In Accounts Receivable | -$13.8K | $10.2K | $4.9K |
| Net Cash Provided By Used In Financing Activities | $341.8K | $471.2K | $875.3K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$65.5K | $84.8K | $43.1K |
| Proceeds From Related Party Debt | $105.2K | $398.0K | |
| Proceeds From Issuance Or Sale Of Equity | $244.3K | $70.0K | $802.0K |
| Increase Decrease In Operating Lease Liability | -$21.9K | $22.3K | -$43.4K |
| Increase Decrease In Deferred Revenue | $0.00 | -$28.6K | $28.6K |
| Proceeds From Short Term Debt | $29.9K | $73.3K | |
| Proceeds From Repayments Of Related Party Debt | $398.0K | $0.00 | |
| Share Based Compensation | $0.00 | $12.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$103.7K | -$30.4K | -$74.6K |
| Increase Decrease In Accounts Receivable | $2.6K | -$3.0K | $17.4K |
| Net Cash Provided By Used In Financing Activities | $30.6K | $70.5K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $952.00 | -$59.8K | $58.7K |
| Proceeds From Related Party Debt | $93.8K | $69.1K | |
| Proceeds From Issuance Or Sale Of Equity | $0.00 | $75.0K | |
| Increase Decrease In Operating Lease Liability | -$2.1K | -$4.6K | |
| Increase Decrease In Deferred Revenue | $12.0K | $0.00 | -$8.3K |
| Proceeds From Short Term Debt | -$38.6K | $33.5K | |
| Proceeds From Repayments Of Related Party Debt | $69.1K | $0.00 | |
| Share Based Compensation |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Diluted EPS * | -$0.00 | -$0.00 | -$0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 10.72B | 10.32B | 9.00B |
| Weighted Average Number Of Diluted Shares Outstanding | 10.72B | 10.32B | 9.00B |
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | |
| Common Stock Shares Outstanding | 10.43B | 10.06B | |
| Common Stock Shares Authorized | 20.00B | 20.00B | |
| Common Stock Shares Issued | 10.43B | 10.06B | |
| Preferred Stock Shares Outstanding | 2.0K | 1.0K | |
| Weighted Average Shares Outstanding Basic And Dilutive |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q1 2012 | Q4 2011 | Q2 2011 | Q1 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.09 | $0.13 | -$0.13 | $0.38 | ||
| Weighted Average Number Of Shares Outstanding Basic | 11.63B | 11.63B | 10.50B | 10.46B | 10.37B | 10.33B | 10.33B | 7.86B | 8.09B | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 11.63B | 11.63B | 10.50B | 10.46B | 10.37B | 10.33B | 10.33B | 7.86B | 8.09B | ||||||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||
| Common Stock Shares Outstanding | 11.63B | 11.63B | 11.63B | 10.56B | 10.43B | 10.33B | 14.1M | 12.9M | 12.9M | ||||||
| Common Stock Shares Authorized | 20.00B | 20.00B | 20.00B | 20.00B | 20.00B | 20.00B | 100.0M | 100.0M | 100.0M | ||||||
| Common Stock Shares Issued | 11.63B | 11.63B | 11.63B | 10.56B | 10.43B | 10.06B | 14.1M | 14.1M | 12.9M | ||||||
| Preferred Stock Shares Outstanding | 2.0K | 0.00 | 0.00 | 0.00 | |||||||||||
| Weighted Average Shares Outstanding Basic And Dilutive | 13.5M | 13.5M | 12.9M | 12.9M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Travel And Entertainment Expense | $517.00 | $2.1K | $6.6K |
| Professional Fees | $317.1K | $232.8K | $245.7K |
| Officers Compensation | $24.0K | $38.0K | $45.7K |
| Labor And Related Expense | $175.4K | $206.0K | $659.7K |
| Other Short Term Borrowings | $136.2K | $121.4K | |
| Interest Paid Net | $136.3K | $93.5K | $93.5K |
| Additional Paid In Capital | $4.3M | $4.1M | |
| Stock Issued During Period Value New Issues | $158.0K | $70.0K | $802.0K |
| Issuance Of Stock And Warrants For Services Or Claims | $220.0K | $113.0K | |
| Bank Overdrafts | $0.00 | $2.4K | $0.00 |
| Manufacturing Service Cost | |||
| Manufacturing Service | |||
| Investment Income Interest |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2012 | Q4 2011 | Q1 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Travel And Entertainment Expense | $62.00 | $213.00 | $97.00 | $142.00 | $378.00 | $197.00 | $1.7K | $1.8K | $1.5K | ||||||
| Professional Fees | $52.0K | $7.7K | $7.1K | $36.6K | $95.1K | $45.0K | $62.4K | $65.6K | $16.0K | ||||||
| Officers Compensation | $8.1K | $6.0K | $6.0K | $6.0K | $8.0K | $12.0K | $12.0K | $10.7K | $13.5K | ||||||
| Labor And Related Expense | $36.1K | $42.5K | $54.3K | $45.9K | $38.3K | $46.3K | $95.7K | $165.6K | $189.2K | ||||||
| Other Short Term Borrowings | $111.7K | $111.7K | $111.7K | $112.6K | $151.3K | $151.3K | |||||||||
| Interest Paid Net | $136.3K | $2.3K | $5.0K | ||||||||||||
| Additional Paid In Capital | $4.7M | $4.7M | $4.7M | $4.4M | $4.2M | $4.1M | |||||||||
| Stock Issued During Period Value New Issues | $0.00 | $75.0K | $75.0K | $248.3K | $312.7K | $75.0K | |||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $0.00 | $100.0K | |||||||||||||
| Bank Overdrafts | $1.5K | $5.5K | $3.8K | ||||||||||||
| Manufacturing Service Cost | $95.6K | $131.3K | $710.9K | $964.6K | |||||||||||
| Manufacturing Service | $113.0K | $484.3K | $2.6M | $3.0M | |||||||||||
| Investment Income Interest | $0.00 | $0.00 | $9.2K | $450.00 |
Most recent annual filing with the SEC: September 22, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.